Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? : A protocol for the MEL-SELF randomised controlled trial

Ackermann, D M, Smit, A K, Janda, M, van Kemenade, C H, Dieng, M, Morton, R L, Turner, R M, Cust, A E, Irwig, L, Hersch, J K, Guitera, P, Soyer, H P, Mar, V, Saw, R P M, Low, D, Low, C, Drabarek, D, Espinoza, D, Emery, J, Murchie, P, Thompson, J F, Scolyer, R A, Azzi, A, Lilleyman, A & Bell, K J L 2021, 'Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial', Trials, vol. 22, no. 1, 324. https://doi.org/10.1186/s13063-021-05231-7